One Retinoblastoma World 2020: Retinoblastoma Genetics
Panel on Retinoblastoma Genetics at One Retinoblastoma World 2020 Conference held virtually on October 3 & 4, 2020.
Hosted by World Eye Cancer Hope, International Retinoblastoma Consortium, Canadian Retinoblastoma Research Advisory Board, and Canadian Retinoblastoma Society.
For more information visit: https://wechope.org/onerbworld/
Helen Dimaras, PhD, Scientist, The Hospital for Sick Children (SickKids), Toronto, Canada; Associate Professor, The University of Toronto, Canada; Founder, Canadian Retinoblastoma Research Advisory Board; Scientific Director, World Eye Cancer Hope.
Melissa B. Mills, MS, CGC, LGC, Genetic Counsellor, Lucile Packard Children’s Hospital Stanford, Palo Alto, California; Retinoblastoma Survivor.
Jesse L. Berry, MD, Associate Director of Ocular Oncology & Attending Physician, Children’s Hospital Los Angeles, Los Angeles, USA; Associate Professor of Ophthalmology (Clinical Scholar), University of Southern California Keck School of Medicine Roski Eye Institute, Los Angeles, USA.
Lucy Njambi, MBChB, MMed (Ophth), Pediatric Ophthalmologist, Kenyatta National Hospital, Nairobi, Kenya; Lecturer, University of Nairobi, Nairobi, Kenya.
Laura Kelly, Retinoblastoma Survivor, Halifax, Canada.
Effectively conveying genetic information is essential for patients to make informed decisions. This is especially important for survivors of heritable cancers such as retinoblastoma. Panelists in this session will share the current state of knowledge and provide examples of lived experience related to the genetics of retinoblastoma. Specifically, the session will explore: the cause of retinoblastoma; second primary cancer risks; family planning; genetic counselling services; and new genetic research studies.
-
Category
No comments found